Your browser doesn't support javascript.
loading
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study.
Selke Krulichová, Iva; Selke, Gisbert W; Bennie, Marion; Hajiebrahimi, Mohammadhossein; Nyberg, Fredrik; Fürst, Jurij; Garuoliene, Kristina; Poluzzi, Elisabetta; Slabý, Juraj; Yahni, Corinne Zara; Altini, Mattia; Fantini, Maria Pia; Kocí, Václav; McTaggart, Stuart; Pontes, Caridad; Reno, Chiara; Rosa, Simona; Pedrola, Marta Turu; Udovic, Mitja; Wettermark, Björn.
Afiliação
  • Selke Krulichová I; Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Selke GW; Pharmaceuticals Information Systems and Analyses, AOK Research Institute (WIdO), Berlin, Germany.
  • Bennie M; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Hajiebrahimi M; Public Health and Intelligence, Public Health Scotland, Edinburgh, UK.
  • Nyberg F; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Fürst J; School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
  • Garuoliene K; Department of Medicinal Products, Health Insurance Institute of Slovenia, Ljubljana, Slovenia.
  • Poluzzi E; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Slabý J; Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
  • Yahni CZ; Section of Pricing and Reimbursement Regulation, State Institute for Drug Control, Praha, Czech Republic.
  • Altini M; Drug Department, Catalan Health Service, Barcelona, Spain.
  • Fantini MP; Healthcare Administration, Azienda Unità Sanitaria Locale della Romagna, Ravenna, Italy.
  • Kocí V; Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
  • McTaggart S; Section of Pricing and Reimbursement Regulation, State Institute for Drug Control, Praha, Czech Republic.
  • Pontes C; Public Health and Intelligence, Public Health Scotland, Edinburgh, UK.
  • Reno C; Drug Department, Catalan Health Service, Barcelona, Spain.
  • Rosa S; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Pedrola MT; Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
  • Udovic M; Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
  • Wettermark B; Drug Department, Catalan Health Service, Barcelona, Spain.
Pharmacoepidemiol Drug Saf ; 31(10): 1046-1055, 2022 10.
Article em En | MEDLINE | ID: mdl-35791700
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Assunto da revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Assunto da revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca